Video

Dr. Goy on the Upcoming Conference at the JTCC

Dr. Andre Goy from John Theurer Cancer Center on the Upcoming Conference at John Theurer Cancer Center

Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, recognizes that this is a very exciting time for the field of oncology. There are multiple novel therapies, predictors, and biomarkers currently being investigated. It is a daunting task for the busy oncology specialist to keep up on all this new information.

The upcoming New Frontiers in the Management of Solid and Liquid Tumors at John Theurer Cancer Center at Hackensack University Medical Center, November 3-4, 2011, will broadly explain the recent advances in these multiple fields. This information will help the clinician manage patients by facilitating the application of this knowledge into practice.

Learn more about the New Frontiers In The Management of Solid and Liquid Tumors.

Related Videos
Minoo Battiwalla, MD, MS
Cynthia X. Ma, MD, PhD
Jyoti Patel, MD
Leo I. Gordon, MD
Bertram Yuh, MD, MISM, MSHCPM
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the treatment goals in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss factors for picking intensive chemotherapy vs other regimens in acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss long-term data for CPX-351 in acute myeloid leukemia.